Skip to main content

Sensex jumps 500 points, Nifty eyes 11,900; 5 factors that triggered rally

Bank stocks rallied, giving a solid base to the benchmark indices after the Q2FY21 results of HDFC Bank cheered investors.

The Sensex and the Nifty carried forward the previous session's gains in the morning trade on October 19 as both indices jumped over a percent higher.

The Sensex rose more than 500 points and the Nifty touched 11,892 within the first hour of the trade. At 1035 hours, the Sensex was 449 points, or 1.12 percent, up at 40,432 while the Nifty was trading 117 points, or 1 percent, higher at 11,879.50. BSE Midcap and smallcap indices were 0.21 percent and 0.39 percent up, respectively.

Sectorally, BSE Bankex jumped over 2 percent and finance and energy climbed 2 percent.



Here are five factors that triggered the market rally:

Positive global cues

The Indian market rose in sync with most of the Asian peers. As per Reuters, Japanese shares gained more than 1 percent on October 19, tracking Wall Street futures higher in early Asian trade, on hopes of a new US coronavirus relief deal before the presidential election.

Bank stocks rally

Bank stocks rallied, giving a solid base to the benchmark indices after the Q2FY21 results of HDFC Bank cheered investors.

HDFC Bank, the country's largest private sector lender, reported an 18.4 percent year-on-year growth in profit at Rs 7,513.11 crore for the September quarter, driven by PPoP, NII and lower tax rate. The profit in the year-ago period was at Rs 6,345 crore.

Encouraging reports on COVID-19 front

A government-appointed panel on October 18 said the COVID-19 pandemic had peaked in India and could be brought under control by early next year with "minimal active cases by February-end" if protective measures are followed.

According to reports, the 'COVID-19 India National Supermodel' committee, led by Professor M Vidyasagar of the Indian Institute of Technology (IIT) Hyderabad, revealed the findings in a study titled Progression of the COVID-19 pandemic in India: Prognosis and Lockdown Impacts. According to the study, the number of infections in the country by the time the epidemic ends would be 105 lakh. India has already reported more than 75 lakh cases.

Earnings on expected lines

The September quarter earnings have largely been on expected lines, so far, and have been better than the expectations in some cases as well.

The numbers of TCS, Infosys and HDFC Bank have been able to keep the market sentiment up.

China's swift economic recovery

Media reports suggest that China's economic recovery quickened in the third quarter even as overall growth missed the forecast.

As per Reuters, China’s economic recovery accelerated in the third quarter as consumers shook off their coronavirus caution, however, overall growth missed forecasts, pointing to persistent challenges for one of the world’s few current engines of demand.

Source - Moneycontrol.com

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more